ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bronchodilator Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-21Z7271
Home | Market Reports | Health| Health Conditions| Respiratory Conditions
Global Bronchodilator Market Insights and Forecast to 2028
BUY CHAPTERS

Global Bronchodilator Market Research Report 2025

Code: QYRE-Auto-21Z7271
Report
August 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GlaxoSmithKline PLC
Roche
Astrazeneca plc
Boehringer Ingelheim
Amgen Inc
Kissei Pharmaceutical
Mitsubishi Tanabe Pharma
Sanofi
Theron Pharmaceuticals
Array BioPharma
Kyowa Hakko Kirin
Verona Pharma
Nycomed Pharma

Bronchodilator Market Size

The global market for Bronchodilator was valued at US$ 33970 million in the year 2024 and is projected to reach a revised size of US$ 45660 million by 2031, growing at a CAGR of 4.4% during the forecast period.

Bronchodilator Market

Bronchodilator Market

North American market for Bronchodilator is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Bronchodilator is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Bronchodilator include GlaxoSmithKline, Roche, AstraZeneca, Boehringer Ingelheim, Amgen, Kissei Pharmaceutical, Mitsubishi Tanabe Pharma, Sanofi, Theron Pharmaceuticals, Array BioPharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bronchodilator, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bronchodilator.
The Bronchodilator market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bronchodilator market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bronchodilator manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Bronchodilator Market Report

Report Metric Details
Report Name Bronchodilator Market
Accounted market size in year US$ 33970 million
Forecasted market size in 2031 US$ 45660 million
CAGR 4.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Short-acting Bronchodilator
  • Long-acting Bronchodilator
Segment by Application
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline, Roche, AstraZeneca, Boehringer Ingelheim, Amgen, Kissei Pharmaceutical, Mitsubishi Tanabe Pharma, Sanofi, Theron Pharmaceuticals, Array BioPharma, Kyowa Hakko Kirin, Verona Pharma, Nycomed Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Bronchodilator manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Bronchodilator in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Bronchodilator Market growing?

Ans: The Bronchodilator Market witnessing a CAGR of 4.4% during the forecast period 2025-2031.

What is the Bronchodilator Market size in 2031?

Ans: The Bronchodilator Market size in 2031 will be US$ 45660 million.

Who are the main players in the Bronchodilator Market report?

Ans: The main players in the Bronchodilator Market are GlaxoSmithKline, Roche, AstraZeneca, Boehringer Ingelheim, Amgen, Kissei Pharmaceutical, Mitsubishi Tanabe Pharma, Sanofi, Theron Pharmaceuticals, Array BioPharma, Kyowa Hakko Kirin, Verona Pharma, Nycomed Pharma

What are the Application segmentation covered in the Bronchodilator Market report?

Ans: The Applications covered in the Bronchodilator Market report are Asthma, Chronic Obstructive Pulmonary Disease, Others

What are the Type segmentation covered in the Bronchodilator Market report?

Ans: The Types covered in the Bronchodilator Market report are Short-acting Bronchodilator, Long-acting Bronchodilator

1 Bronchodilator Market Overview
1.1 Product Definition
1.2 Bronchodilator by Type
1.2.1 Global Bronchodilator Market Value Comparison by Type (2024 VS 2031)
1.2.2 Short-acting Bronchodilator
1.2.3 Long-acting Bronchodilator
1.3 Bronchodilator by Application
1.3.1 Global Bronchodilator Market Value by Application (2024 VS 2031)
1.3.2 Asthma
1.3.3 Chronic Obstructive Pulmonary Disease
1.3.4 Others
1.4 Global Bronchodilator Market Size Estimates and Forecasts
1.4.1 Global Bronchodilator Revenue 2020-2031
1.4.2 Global Bronchodilator Sales 2020-2031
1.4.3 Global Bronchodilator Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Bronchodilator Market Competition by Manufacturers
2.1 Global Bronchodilator Sales Market Share by Manufacturers (2020-2025)
2.2 Global Bronchodilator Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Bronchodilator Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Bronchodilator, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bronchodilator, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bronchodilator, Product Type & Application
2.7 Global Key Manufacturers of Bronchodilator, Date of Enter into This Industry
2.8 Global Bronchodilator Market Competitive Situation and Trends
2.8.1 Global Bronchodilator Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Bronchodilator Players Market Share by Revenue
2.8.3 Global Bronchodilator Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Bronchodilator Market Scenario by Region
3.1 Global Bronchodilator Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Bronchodilator Sales by Region: 2020-2031
3.2.1 Global Bronchodilator Sales by Region: 2020-2025
3.2.2 Global Bronchodilator Sales by Region: 2026-2031
3.3 Global Bronchodilator Revenue by Region: 2020-2031
3.3.1 Global Bronchodilator Revenue by Region: 2020-2025
3.3.2 Global Bronchodilator Revenue by Region: 2026-2031
3.4 North America Bronchodilator Market Facts & Figures by Country
3.4.1 North America Bronchodilator Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Bronchodilator Sales by Country (2020-2031)
3.4.3 North America Bronchodilator Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Bronchodilator Market Facts & Figures by Country
3.5.1 Europe Bronchodilator Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Bronchodilator Sales by Country (2020-2031)
3.5.3 Europe Bronchodilator Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bronchodilator Market Facts & Figures by Region
3.6.1 Asia Pacific Bronchodilator Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Bronchodilator Sales by Region (2020-2031)
3.6.3 Asia Pacific Bronchodilator Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Bronchodilator Market Facts & Figures by Country
3.7.1 Latin America Bronchodilator Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Bronchodilator Sales by Country (2020-2031)
3.7.3 Latin America Bronchodilator Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bronchodilator Market Facts & Figures by Country
3.8.1 Middle East and Africa Bronchodilator Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Bronchodilator Sales by Country (2020-2031)
3.8.3 Middle East and Africa Bronchodilator Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bronchodilator Sales by Type (2020-2031)
4.1.1 Global Bronchodilator Sales by Type (2020-2025)
4.1.2 Global Bronchodilator Sales by Type (2026-2031)
4.1.3 Global Bronchodilator Sales Market Share by Type (2020-2031)
4.2 Global Bronchodilator Revenue by Type (2020-2031)
4.2.1 Global Bronchodilator Revenue by Type (2020-2025)
4.2.2 Global Bronchodilator Revenue by Type (2026-2031)
4.2.3 Global Bronchodilator Revenue Market Share by Type (2020-2031)
4.3 Global Bronchodilator Price by Type (2020-2031)
5 Segment by Application
5.1 Global Bronchodilator Sales by Application (2020-2031)
5.1.1 Global Bronchodilator Sales by Application (2020-2025)
5.1.2 Global Bronchodilator Sales by Application (2026-2031)
5.1.3 Global Bronchodilator Sales Market Share by Application (2020-2031)
5.2 Global Bronchodilator Revenue by Application (2020-2031)
5.2.1 Global Bronchodilator Revenue by Application (2020-2025)
5.2.2 Global Bronchodilator Revenue by Application (2026-2031)
5.2.3 Global Bronchodilator Revenue Market Share by Application (2020-2031)
5.3 Global Bronchodilator Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Bronchodilator Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GlaxoSmithKline Bronchodilator Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Roche
6.2.1 Roche Company Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Bronchodilator Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Roche Bronchodilator Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Company Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Bronchodilator Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AstraZeneca Bronchodilator Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Company Information
6.4.2 Boehringer Ingelheim Description and Business Overview
6.4.3 Boehringer Ingelheim Bronchodilator Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Boehringer Ingelheim Bronchodilator Product Portfolio
6.4.5 Boehringer Ingelheim Recent Developments/Updates
6.5 Amgen
6.5.1 Amgen Company Information
6.5.2 Amgen Description and Business Overview
6.5.3 Amgen Bronchodilator Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Amgen Bronchodilator Product Portfolio
6.5.5 Amgen Recent Developments/Updates
6.6 Kissei Pharmaceutical
6.6.1 Kissei Pharmaceutical Company Information
6.6.2 Kissei Pharmaceutical Description and Business Overview
6.6.3 Kissei Pharmaceutical Bronchodilator Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Kissei Pharmaceutical Bronchodilator Product Portfolio
6.6.5 Kissei Pharmaceutical Recent Developments/Updates
6.7 Mitsubishi Tanabe Pharma
6.7.1 Mitsubishi Tanabe Pharma Company Information
6.7.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.7.3 Mitsubishi Tanabe Pharma Bronchodilator Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Mitsubishi Tanabe Pharma Bronchodilator Product Portfolio
6.7.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Company Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Bronchodilator Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sanofi Bronchodilator Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Theron Pharmaceuticals
6.9.1 Theron Pharmaceuticals Company Information
6.9.2 Theron Pharmaceuticals Description and Business Overview
6.9.3 Theron Pharmaceuticals Bronchodilator Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Theron Pharmaceuticals Bronchodilator Product Portfolio
6.9.5 Theron Pharmaceuticals Recent Developments/Updates
6.10 Array BioPharma
6.10.1 Array BioPharma Company Information
6.10.2 Array BioPharma Description and Business Overview
6.10.3 Array BioPharma Bronchodilator Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Array BioPharma Bronchodilator Product Portfolio
6.10.5 Array BioPharma Recent Developments/Updates
6.11 Kyowa Hakko Kirin
6.11.1 Kyowa Hakko Kirin Company Information
6.11.2 Kyowa Hakko Kirin Description and Business Overview
6.11.3 Kyowa Hakko Kirin Bronchodilator Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Kyowa Hakko Kirin Bronchodilator Product Portfolio
6.11.5 Kyowa Hakko Kirin Recent Developments/Updates
6.12 Verona Pharma
6.12.1 Verona Pharma Company Information
6.12.2 Verona Pharma Description and Business Overview
6.12.3 Verona Pharma Bronchodilator Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Verona Pharma Bronchodilator Product Portfolio
6.12.5 Verona Pharma Recent Developments/Updates
6.13 Nycomed Pharma
6.13.1 Nycomed Pharma Company Information
6.13.2 Nycomed Pharma Description and Business Overview
6.13.3 Nycomed Pharma Bronchodilator Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Nycomed Pharma Bronchodilator Product Portfolio
6.13.5 Nycomed Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bronchodilator Industry Chain Analysis
7.2 Bronchodilator Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bronchodilator Production Mode & Process Analysis
7.4 Bronchodilator Sales and Marketing
7.4.1 Bronchodilator Sales Channels
7.4.2 Bronchodilator Distributors
7.5 Bronchodilator Customer Analysis
8 Bronchodilator Market Dynamics
8.1 Bronchodilator Industry Trends
8.2 Bronchodilator Market Drivers
8.3 Bronchodilator Market Challenges
8.4 Bronchodilator Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GlaxoSmithKline PLC
Roche
Astrazeneca plc
Boehringer Ingelheim
Amgen Inc
Kissei Pharmaceutical
Mitsubishi Tanabe Pharma
Sanofi
Theron Pharmaceuticals
Array BioPharma
Kyowa Hakko Kirin
Verona Pharma
Nycomed Pharma
List of Tables
 Table 1. Global Bronchodilator Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Bronchodilator Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Bronchodilator Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Bronchodilator Sales (K Doses) of Key Manufacturers (2020-2025)
 Table 5. Global Bronchodilator Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Bronchodilator Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Bronchodilator Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Bronchodilator Average Price (USD/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Bronchodilator, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Bronchodilator, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Bronchodilator, Product Type & Application
 Table 12. Global Key Manufacturers of Bronchodilator, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Bronchodilator by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bronchodilator as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Bronchodilator Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Bronchodilator Sales by Region (2020-2025) & (K Doses)
 Table 18. Global Bronchodilator Sales Market Share by Region (2020-2025)
 Table 19. Global Bronchodilator Sales by Region (2026-2031) & (K Doses)
 Table 20. Global Bronchodilator Sales Market Share by Region (2026-2031)
 Table 21. Global Bronchodilator Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Bronchodilator Revenue Market Share by Region (2020-2025)
 Table 23. Global Bronchodilator Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Bronchodilator Revenue Market Share by Region (2026-2031)
 Table 25. North America Bronchodilator Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Bronchodilator Sales by Country (2020-2025) & (K Doses)
 Table 27. North America Bronchodilator Sales by Country (2026-2031) & (K Doses)
 Table 28. North America Bronchodilator Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Bronchodilator Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Bronchodilator Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Bronchodilator Sales by Country (2020-2025) & (K Doses)
 Table 32. Europe Bronchodilator Sales by Country (2026-2031) & (K Doses)
 Table 33. Europe Bronchodilator Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Bronchodilator Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Bronchodilator Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Bronchodilator Sales by Region (2020-2025) & (K Doses)
 Table 37. Asia Pacific Bronchodilator Sales by Region (2026-2031) & (K Doses)
 Table 38. Asia Pacific Bronchodilator Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Bronchodilator Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Bronchodilator Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Bronchodilator Sales by Country (2020-2025) & (K Doses)
 Table 42. Latin America Bronchodilator Sales by Country (2026-2031) & (K Doses)
 Table 43. Latin America Bronchodilator Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Bronchodilator Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Bronchodilator Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Bronchodilator Sales by Country (2020-2025) & (K Doses)
 Table 47. Middle East and Africa Bronchodilator Sales by Country (2026-2031) & (K Doses)
 Table 48. Middle East and Africa Bronchodilator Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Bronchodilator Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Bronchodilator Sales (K Doses) by Type (2020-2025)
 Table 51. Global Bronchodilator Sales (K Doses) by Type (2026-2031)
 Table 52. Global Bronchodilator Sales Market Share by Type (2020-2025)
 Table 53. Global Bronchodilator Sales Market Share by Type (2026-2031)
 Table 54. Global Bronchodilator Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Bronchodilator Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Bronchodilator Revenue Market Share by Type (2020-2025)
 Table 57. Global Bronchodilator Revenue Market Share by Type (2026-2031)
 Table 58. Global Bronchodilator Price (USD/Dose) by Type (2020-2025)
 Table 59. Global Bronchodilator Price (USD/Dose) by Type (2026-2031)
 Table 60. Global Bronchodilator Sales (K Doses) by Application (2020-2025)
 Table 61. Global Bronchodilator Sales (K Doses) by Application (2026-2031)
 Table 62. Global Bronchodilator Sales Market Share by Application (2020-2025)
 Table 63. Global Bronchodilator Sales Market Share by Application (2026-2031)
 Table 64. Global Bronchodilator Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Bronchodilator Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Bronchodilator Revenue Market Share by Application (2020-2025)
 Table 67. Global Bronchodilator Revenue Market Share by Application (2026-2031)
 Table 68. Global Bronchodilator Price (USD/Dose) by Application (2020-2025)
 Table 69. Global Bronchodilator Price (USD/Dose) by Application (2026-2031)
 Table 70. GlaxoSmithKline Company Information
 Table 71. GlaxoSmithKline Description and Business Overview
 Table 72. GlaxoSmithKline Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 73. GlaxoSmithKline Bronchodilator Product
 Table 74. GlaxoSmithKline Recent Developments/Updates
 Table 75. Roche Company Information
 Table 76. Roche Description and Business Overview
 Table 77. Roche Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 78. Roche Bronchodilator Product
 Table 79. Roche Recent Developments/Updates
 Table 80. AstraZeneca Company Information
 Table 81. AstraZeneca Description and Business Overview
 Table 82. AstraZeneca Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 83. AstraZeneca Bronchodilator Product
 Table 84. AstraZeneca Recent Developments/Updates
 Table 85. Boehringer Ingelheim Company Information
 Table 86. Boehringer Ingelheim Description and Business Overview
 Table 87. Boehringer Ingelheim Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 88. Boehringer Ingelheim Bronchodilator Product
 Table 89. Boehringer Ingelheim Recent Developments/Updates
 Table 90. Amgen Company Information
 Table 91. Amgen Description and Business Overview
 Table 92. Amgen Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 93. Amgen Bronchodilator Product
 Table 94. Amgen Recent Developments/Updates
 Table 95. Kissei Pharmaceutical Company Information
 Table 96. Kissei Pharmaceutical Description and Business Overview
 Table 97. Kissei Pharmaceutical Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 98. Kissei Pharmaceutical Bronchodilator Product
 Table 99. Kissei Pharmaceutical Recent Developments/Updates
 Table 100. Mitsubishi Tanabe Pharma Company Information
 Table 101. Mitsubishi Tanabe Pharma Description and Business Overview
 Table 102. Mitsubishi Tanabe Pharma Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 103. Mitsubishi Tanabe Pharma Bronchodilator Product
 Table 104. Mitsubishi Tanabe Pharma Recent Developments/Updates
 Table 105. Sanofi Company Information
 Table 106. Sanofi Description and Business Overview
 Table 107. Sanofi Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 108. Sanofi Bronchodilator Product
 Table 109. Sanofi Recent Developments/Updates
 Table 110. Theron Pharmaceuticals Company Information
 Table 111. Theron Pharmaceuticals Description and Business Overview
 Table 112. Theron Pharmaceuticals Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 113. Theron Pharmaceuticals Bronchodilator Product
 Table 114. Theron Pharmaceuticals Recent Developments/Updates
 Table 115. Array BioPharma Company Information
 Table 116. Array BioPharma Description and Business Overview
 Table 117. Array BioPharma Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 118. Array BioPharma Bronchodilator Product
 Table 119. Array BioPharma Recent Developments/Updates
 Table 120. Kyowa Hakko Kirin Company Information
 Table 121. Kyowa Hakko Kirin Description and Business Overview
 Table 122. Kyowa Hakko Kirin Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 123. Kyowa Hakko Kirin Bronchodilator Product
 Table 124. Kyowa Hakko Kirin Recent Developments/Updates
 Table 125. Verona Pharma Company Information
 Table 126. Verona Pharma Description and Business Overview
 Table 127. Verona Pharma Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 128. Verona Pharma Bronchodilator Product
 Table 129. Verona Pharma Recent Developments/Updates
 Table 130. Nycomed Pharma Company Information
 Table 131. Nycomed Pharma Description and Business Overview
 Table 132. Nycomed Pharma Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 133. Nycomed Pharma Bronchodilator Product
 Table 134. Nycomed Pharma Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Bronchodilator Distributors List
 Table 138. Bronchodilator Customers List
 Table 139. Bronchodilator Market Trends
 Table 140. Bronchodilator Market Drivers
 Table 141. Bronchodilator Market Challenges
 Table 142. Bronchodilator Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Bronchodilator
 Figure 2. Global Bronchodilator Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Bronchodilator Market Share by Type: 2024 & 2031
 Figure 4. Short-acting Bronchodilator Product Picture
 Figure 5. Long-acting Bronchodilator Product Picture
 Figure 6. Global Bronchodilator Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Bronchodilator Market Share by Application: 2024 & 2031
 Figure 8. Asthma
 Figure 9. Chronic Obstructive Pulmonary Disease
 Figure 10. Others
 Figure 11. Global Bronchodilator Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Bronchodilator Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Bronchodilator Sales (2020-2031) & (K Doses)
 Figure 14. Global Bronchodilator Average Price (USD/Dose) & (2020-2031)
 Figure 15. Bronchodilator Report Years Considered
 Figure 16. Bronchodilator Sales Share by Manufacturers in 2024
 Figure 17. Global Bronchodilator Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Bronchodilator Players: Market Share by Revenue in Bronchodilator in 2024
 Figure 19. Bronchodilator Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Bronchodilator Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Bronchodilator Sales Market Share by Country (2020-2031)
 Figure 22. North America Bronchodilator Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Bronchodilator Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Bronchodilator Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Bronchodilator Sales Market Share by Country (2020-2031)
 Figure 26. Europe Bronchodilator Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Bronchodilator Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Bronchodilator Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Bronchodilator Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Bronchodilator Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Bronchodilator Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Bronchodilator Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Bronchodilator Revenue Market Share by Region (2020-2031)
 Figure 34. China Bronchodilator Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Bronchodilator Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Bronchodilator Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Bronchodilator Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Bronchodilator Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Bronchodilator Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Bronchodilator Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Bronchodilator Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Bronchodilator Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Bronchodilator Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Bronchodilator Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Bronchodilator Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Bronchodilator Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Bronchodilator Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Bronchodilator Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Bronchodilator Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Bronchodilator Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Bronchodilator Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Bronchodilator Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Bronchodilator Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Bronchodilator by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Bronchodilator by Type (2020-2031)
 Figure 56. Global Bronchodilator Price (USD/Dose) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Bronchodilator by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Bronchodilator by Application (2020-2031)
 Figure 59. Global Bronchodilator Price (USD/Dose) by Application (2020-2031)
 Figure 60. Bronchodilator Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Bronchodilator Inhalers Market Research Report 2025
Global Aerosol Bronchodilator Market Research Report 2025
Global Inhalers Market Research Report 2024
Global Desktop Spirometer Market Research Report 2025
Electronic Bronchoscope Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Inotropic Agent Market Research Report 2025
Global Asthma Inhalers Market Research Report 2025
Global Bronchial Stents Market Research Report 2025
Global Adrenergic Agonist Market Research Report 2024
Global Borazole Market Research Report 2024
Global Airway Lung Stent Market Research Report 2024
Global Inflators Market Research Report 2025
Global Diaphragm Carburetor Market Research Report 2024
Global Bronchitis Drug Market Research Report 2024
Global Bronchopulmonary Dysplasia Drug Market Research Report 2024
Global Bronchitis Treatment Drug Market Research Report 2025
Global Household Spirometer Market Research Report 2025
Asthma and COPD Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Therapeutic Bronchoscope Market Research Report 2024
Global Manometer Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions